US OptionsDetailed Quotes
ABBV241101C220000
- 0.01
- -0.12-92.31%
15min DelayClose Oct 30 15:59 ET
0.01High0.01Low
0.01Open0.13Pre Close5 Volume24 Open Interest220.00Strike Price5.00Turnover54.96%IV9.19%PremiumNov 1, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0047Delta0.0020Gamma20150.00Leverage Ratio-0.0100Theta0.0000Rho95.59Eff Leverage0.0017Vega
AbbVie Stock Discussion
Sign in to post a comment
US Market Key Charts (S&P, US Dollar, Gold)
$E-mini S&P 500 Futures(DEC4) (ESmain.US)$ (4 Hour Chart) -[BULLISH↗ *]We stay bullish as long as price holds above 5815 support level. We expect price to push towards 5930 resistance level. A 4 hour candlestick closing above 5930 resistance level would open next push towards 5990 resistance level. Technical indicators are mixed, with prices holding above 21-EMA period.
Alternatively: A 4 hour candlestick c...
$E-mini S&P 500 Futures(DEC4) (ESmain.US)$ (4 Hour Chart) -[BULLISH↗ *]We stay bullish as long as price holds above 5815 support level. We expect price to push towards 5930 resistance level. A 4 hour candlestick closing above 5930 resistance level would open next push towards 5990 resistance level. Technical indicators are mixed, with prices holding above 21-EMA period.
Alternatively: A 4 hour candlestick c...
25
3
The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
+7
75
9
Recent data shows that defensive sectors like utilities, consumer defensive, and healthcare have outperformed the information technology sector over the past month, reaching 52-week highs.
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...
272
111
$AbbVie (ABBV.US)$ too strong 💪 waiting to buy in at $180
finally green again after the last few weeks. still don't know what I'm doing, but trying to learn
loading...
11
3
$Verizon (VZ.US)$ $Cadence Design Systems (CDNS.US)$ $NXP Semiconductors (NXPI.US)$ $Coca-Cola (KO.US)$ $GE Aerospace (GE.US)$ $Spotify Technology (SPOT.US)$ $Alphabet-A (GOOGL.US)$ $Tesla (TSLA.US)$ $Visa (V.US)$ $Texas Instruments (TXN.US)$ $Vertiv Holdings (VRT.US)$ $ServiceNow (NOW.US)$ $KLA Corp (KLAC.US)$ $IBM Corp (IBM.US)$ $Chipotle Mexican Grill (CMG.US)$ $Ford Motor (F.US)$ $AbbVie (ABBV.US)$ $American Airlines (AAL.US)$ $British American Tobacco (BTI.US)$ $Bristol-Myers Squibb (BMY.US)$ $3M (MMM.US)$
📊⚡️📊
📊⚡️📊
7
1
Roughly a quarter of the companies in the S&P 500 are scheduled to release their second-quarter results this week. Investors will be particularly focused on updates from some of the 'Magnificent Seven', which will reveal whether the artificial intelligence (AI) trend continues.
$Alphabet-A (GOOGL.US)$, the parent company of Google, is expected to report revenue of $84.3bn and net income of $23bn, or $1.85 per share, in ...
$Alphabet-A (GOOGL.US)$, the parent company of Google, is expected to report revenue of $84.3bn and net income of $23bn, or $1.85 per share, in ...
+3
102
20
$Genmab (GMAB.US)$ $AbbVie (ABBV.US)$
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
5
$Chevron (CVX.US)$
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
33
3
No comment yet
Cui Nyonya Kueh :
103916021 : k
103677010 : noted